During the course of this work, a study was published showing Gata4 loss was tumorigenic in a Kras-driven GEMM with wild-type p53 but found no role for SASP and further suggested that cell proliferation might be responsible for increased tumor burden30. The gene discussed is GATA4; the disease is neoplasm.